
News and Publications
NEWS
04/04/2023
Arkuda Therapeutics Strengthens Management Team to Support Ongoing Discovery and Translation to the Clinic
Duane Burnett, PhD, appointed Chief Technology Officer, Raymond Hurst, PhD, promoted to Senior Vice President, Head o…
02/09/2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Funding to support progression of lead progranulin enhancer program into IND-enabling studies Small molecule platform…
12/06/2021
Arkuda Therapeutics Awarded Michael J. Fox Foundation Grant to Accelerate Development of Compounds for Parkinson’s Disease
Watertown, MA – December 6, 2021 – Arkuda Therapeutics, a biotechnology company applying new insights at the inte…
PUBLICATIONS
10/07/2021
DISCOVERY OF SMALL MOLECULES FOR THE TREATMENT OF PD-GBA
Natasha Khatri, Mary K. Wozniak, Jerusha K. Brendel, Anna-Maria Alves, Christopher J. Holler, James C. Lanter, Duane …
04/08/2020
DISCOVERY OF NOVEL SMALL MOLECULES FOR THE TREATMENT OF FTD-GRN
Christopher J. Holler, Angela Chen, Natasha Khatri, James C. Lanter, Ricardo L. Sanz, Jerusha K. Brendel, Mary Woznia…
MEDIA CONTACT
Lissette Steele
Verge Scientific Communications
lsteele@vergescientific.com
202.930.4762
